Vivanta Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2026 ,inter alia, to consider and approve Unaudited Standalone and ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Vivanta Industries has called a Board meeting on 24 July 2026 at 4:00 PM to consider and approve its Unaudited Standalone and Consolidated Financial Results for the quarter ended 30 June 2026 (Q1 FY27). The Board will also authorize signatories for the FY26 financial statements and take note of a business collaboration with Qness Pharmaceuticals for manufacture, supply, branding and marketing of pharma products. Other agenda items include noting duplicate share certificate issuances, the Q1 Corporate Governance Report, and the DPT-3 Return of Deposits. The trading window for insiders is already closed and will remain so until 48 hours after results are declared.
Routine board meeting notice; no immediate price impact expected. Investors should watch for the Q1 FY27 results release on/after 24 July and any further details on the pharma collaboration with Qness Pharmaceuticals.